These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 30890364)

  • 1. Combining amorphous solid dispersions for improved kinetic solubility of posaconazole simultaneously released from soluble PVP/VA64 and an insoluble ammonio methacrylate copolymer.
    Danda LJA; Batista LM; Melo VCS; Soares Sobrinho JL; Soares MFR
    Eur J Pharm Sci; 2019 May; 133():79-85. PubMed ID: 30890364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Amorphous Solid Dispersion Sustained-Release Formulations with Polymer Composite Matrix-Regulated Stable Release Plateaus.
    Chen L; Hu E; Shen P; Qian S; Heng W; Zhang J; Gao Y; Wei Y
    Pharm Res; 2024 Jun; 41(6):1233-1245. PubMed ID: 38744732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of Particle Size and Drug Load on Amorphous Solid Dispersions Containing pH-Dependent Soluble Polymers and the Weak Base Ketoconazole.
    Monschke M; Kayser K; Wagner KG
    AAPS PharmSciTech; 2021 Jan; 22(1):44. PubMed ID: 33438107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Processing Methods on the Physico-chemical Properties of Posaconazole Amorphous Solid Dispersions.
    He R; Lamm MS; Brunskill A; Axnanda S; Li Y
    Pharm Res; 2024 Jan; 41(1):141-151. PubMed ID: 38040879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(vinylpyridine-
    Liu YS; Della Rocca J; Schenck L; Koynov A; Sifri RJ; Winston MS; Frank DS
    Mol Pharm; 2024 Mar; 21(3):1182-1191. PubMed ID: 38323546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Amorphous Solid Dispersions of Spironolactone Prepared by Spray Drying and Electrospinning: The Influence of the Preparation Method on the Dissolution Properties.
    Szabó E; Záhonyi P; Brecska D; Galata DL; Mészáros LA; Madarász L; Csorba K; Vass P; Hirsch E; Szafraniec-Szczęsny J; Csontos I; Farkas A; Van denMooter G; Nagy ZK; Marosi G
    Mol Pharm; 2021 Jan; 18(1):317-327. PubMed ID: 33301326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of posaconazole nanocrystalline solid dispersion: preparation, characterization and
    Rayapolu RG; Yadav B; Apte SS; Venuganti VVK
    Pharm Dev Technol; 2024 Jun; 29(5):530-540. PubMed ID: 38713634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface Enrichment and Depletion of Components in a Ternary Drug-Surfactant-Polymer Amorphous Solid Dispersion.
    Borchardt-Setter KA; Yu J; Stelzer T; Yu L
    Mol Pharm; 2024 Aug; 21(8):4074-4081. PubMed ID: 39008633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Terahertz-Raman Spectroscopy to Determine Solubility of the Crystalline Active Pharmaceutical Ingredient in Polymeric Matrices during Hot Melt Extrusion.
    Bordos E; Islam MT; Florence AJ; Halbert GW; Robertson J
    Mol Pharm; 2019 Oct; 16(10):4361-4371. PubMed ID: 31436094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained-release solid dispersion of pelubiprofen using the blended mixture of aminoclay and pH independent polymers: preparation and in vitro/in vivo characterization.
    Lee YS; Song JG; Lee SH; Han HK
    Drug Deliv; 2017 Nov; 24(1):1731-1739. PubMed ID: 29124978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Artificial Gut/Absorption Simulator: Understanding the Impact of Absorption on In Vitro Dissolution, Speciation, and Precipitation of Amorphous Solid Dispersions.
    Jain KMH; Hou HH; Siegel RA
    Mol Pharm; 2024 Apr; 21(4):1884-1899. PubMed ID: 38512389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effect of polymers in stabilizing amorphous pretomanid through high drug loaded amorphous solid dispersion.
    Juneja M; Mehtre K; Saini V; Singh R; Amate P; Kashyap M; Sangamwar AT
    Drug Deliv Transl Res; 2024 Jun; ():. PubMed ID: 38837117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating the influence of protein secondary structure on the dissolution behavior of β-lactoglobulin-based amorphous solid dispersions.
    Zhuo X; Tozzetti M; Arnous A; Leng D; Foderà V; Löbmann K
    Int J Pharm; 2024 Mar; 653():123887. PubMed ID: 38346599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous Water Sorption and Crystallization in ASDs 2: Modeling Long-Term Stabilities.
    Grönniger B; Fritschka E; Kimpe K; Singh A; Sadowski G
    Mol Pharm; 2024 Jun; 21(6):2908-2921. PubMed ID: 38743928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Suitable Polymeric Matrix/Carriers during Loading of Poorly Water Soluble Drugs onto Mesoporous Silica: Physical Stability and In Vitro Supersaturation.
    Kapourani A; Katopodis K; Valkanioti V; Chatzitheodoridou M; Cholevas C; Barmpalexis P
    Polymers (Basel); 2024 Mar; 16(6):. PubMed ID: 38543408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Additives on the Physical Stability and Dissolution of Polymeric Amorphous Solid Dispersions: a Review.
    Li J; Wang Y; Yu D
    AAPS PharmSciTech; 2023 Aug; 24(7):175. PubMed ID: 37603110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solubility and Physical Stability Enhancement of Loratadine by Preparation of Co-Amorphous Solid Dispersion with Chlorpheniramine and Polyvinylpyrrolidone.
    Suknuntha K; Khumpirapang N; Tantishaiyakul V; Okonogi S
    Pharmaceutics; 2023 Oct; 15(11):. PubMed ID: 38004537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the influence of hydrogen bond donor groups on the microstructure and intermolecular interactions of amorphous solid dispersions containing diflunisal structural analogues.
    Cools L; Derveaux E; Reniers F; Dehaen W; Adriaensens P; Van den Mooter G
    Int J Pharm; 2024 Aug; 661():124438. PubMed ID: 38972518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of diluents on the compaction, dissolution, and physical stability of amorphous solid dispersion tablets.
    Yu D; Hoag SW
    Int J Pharm; 2024 Apr; 654():123924. PubMed ID: 38395318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing Nonsink Dissolution Testing for Amorphous Solid Dispersions: Exploring Sample Handling Variables.
    Danda LJA; Amaral ARC; Soares-Sobrinho JL; Soares MFR
    Mol Pharm; 2024 Apr; 21(4):1861-1871. PubMed ID: 38416030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.